Diphtheria,Tetanus,Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine (Wuhan Institute Of Biological Products))
吸附无细胞百白破/b型流感嗜血杆菌联合疫苗 （武汉生物制品）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameDiphtheria,Tetanus,Acellular Pertussis and Haemophilus Influenzae Type b Combined Vaccine (Wuhan Institute Of Biological Products))
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWuhan Institute Of Biological Products Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesWuhan Institute Of Biological Products Co Ltd
Inactive CompaniesN/A
Active Indications +[11]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A